Myelodysplastic Syndromes in Older Adults: Treatment Options and Support Strategies

More than 80% of patients diagnosed with myelodysplastic syndromes (MDS) are over 70 years of age. Care for these patients requires understanding the disease in the context of an older population, and tailoring approaches to both disease risk and patient suitability for therapy.

In this free continuing education series, Marlise R. Luskin, MD, MSCE and Ilene Galinsky BSN, MSN, NP-C will present current research and case examples. Treatment options and common experiences for older patients with MDS and their families will be discussed. CE Credit is available. See full webinar details for more information.

Webinar Details

• Date: Tuesday, May 8, 2018

• Time: 12:00 — 1:15 p.m. CDT

• Speakers:

Marlise R. Luskin, MD, MSCE, Dana-Farber Cancer Institute

Ilene Galinsky BSN, MSN, NP-C, Dana-Farber Cancer Institute (DFCI)

and Brigham and Women’s Hospital (BWH)

Supported by the National Marrow Donor Program® (NMDP), Be The Match® and Aplastic Anemia and MDS International Foundation (AAMDSIF)